CRISPR/Cas9-Based Gene Therapy for Genetic Obesity Syndromes
CRISPR/Cas9 gene therapy offers a promising approach for treating genetic obesity syndromes by targeting specific genes involved in adiposity regulation. This innovative technology enables precise modification of the genome, potencialmente fornecer uma cura para essas condições debilitantes.